Consolidated Statements of Operations and Comprehensive Loss (USD $) In Thousands, except Share data, unless otherwise specified	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011
Revenues	$ 2,344	$ 2,267
Cost of revenues	2,181	1,193
Impairment of inventory	0	368
Gross profit	163	706
Operating expenses
Sales and marketing expenses	1,100	1,023
General and administrative expenses	3,593	3,363
Research and development costs	951	1,634
Total operating expenses	5,644	6,020
Loss from operations before other income (expense)	(5,481)	(5,314)
Other income (expense)
Impairment loss on cash surrender value of life insurance policy	(527)	0
Gain on derecognition of accrued expenses and purchase price guarantee	8,300	0
Loss on extinguishment of debt	(27,479)	0
Gain from change in fair value of hybrid financial instruments	11,926	5,351
Gain (loss) from change in fair value of derivative liability - warrants	11,347	(12,223)
Gain (loss) from change in fair value of derivative liability - Series C and D preferred stock and debentures	(13,035)	15,715
Interest expense	(4,437)	(4,378)
Total other income (expense)	(13,905)	4,465
Net loss	(19,386)	(849)
Dividends on convertible preferred stock	0	0
Net loss attributable to common shareholders	(19,386)	(849)
Comprehensive loss:
Net loss	(19,386)	(849)
Other comprehensive loss item Foreign currency translation adjustment	(56)	(40)
Comprehensive loss	$ (19,442)	$ (889)
Net loss per share, basic and diluted:
Basic (in dollars per share)	$ (0.02)	$ 0.00
Fully diluted (in dollars per share)	$ (0.02)	$ 0.00
Weighted average number of common shares:
Basic (in shares)	1,276,601,569	205,213,037
Fully diluted (in shares)	1,276,601,569	205,213,037